CIAM
Caitong International Asset Management Portfolio holdings
AUM
$140M
This Quarter Return
+37.01%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$140M
AUM Growth
+$5.5M
(+4.1%)
Cap. Flow
-$18.3M
Cap. Flow
% of AUM
-13.08%
Top 10 Holdings %
Top 10 Hldgs %
46.58%
Holding
2,604
New
482
Increased
706
Reduced
691
Closed
662
Top Buys
| 1 |
Palantir
PLTR
|
+$14.1M |
| 2 |
Apple
AAPL
|
+$14.1M |
| 3 |
Plug Power
PLUG
|
+$5.65M |
| 4 |
BigBear.ai
BBAI
|
+$5.14M |
| 5 |
Oracle
ORCL
|
+$4.6M |
Top Sells
| 1 |
MLGO
MicroAlgo
MLGO
|
+$8.47M |
| 2 |
NBIS
Nebius Group N.V. Class A Ordinary Shares
NBIS
|
+$4.68M |
| 3 |
IonQ
IONQ
|
+$4.66M |
| 4 |
Corcept Therapeutics
CORT
|
+$4.29M |
| 5 |
Meta Platforms (Facebook)
META
|
+$3.74M |
Sector Composition
| 1 | Technology | 43.86% |
| 2 | Industrials | 11.85% |
| 3 | Consumer Discretionary | 10.48% |
| 4 | Healthcare | 8.05% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Progress Software
PRGS
$1.85B
| $13.3K | 0.01% |
209
-213
| -50% | -$13.6K |
|
627
Ginkgo Bioworks
DNA
$637M
| $13.3K | 0.01% |
1,182
+60
| +5% | +$675 |
|
628
Monster Beverage
MNST
$61.9B
| $13.3K | 0.01% |
212
+201
| +1,827% | +$12.6K |
|
|
OS
629
OneStream, Inc. Class A Common Stock
OS
$3.69B
| $13.1K | 0.01% |
464
+417
| +887% | +$11.8K |
|
630
Las Vegas Sands
LVS
$37.1B
| $13.1K | 0.01% |
301
-6,299
| -95% | -$274K |
|
631
Unum
UNM
$12.5B
| $13.1K | 0.01% |
162
+24
| +17% | +$1.94K |
|
632
Highwoods Properties
HIW
$3.44B
| $13.1K | 0.01% |
420
+419
| +41,900% | +$13K |
|
633
Zimmer Biomet
ZBH
$20.6B
| $13K | 0.01% |
+143
| New | +$13K |
|
634
Independent Bank
INDB
$3.49B
| $13K | 0.01% |
+207
| New | +$13K |
|
635
Atomera
ATOM
$104M
| $13K | 0.01% |
2,582
+2,137
| +480% | +$10.8K |
|
636
Scorpio Tankers
STNG
$2.91B
| $13K | 0.01% |
331
-3,581
| -92% | -$140K |
|
637
TopBuild
BLD
$11.8B
| $13K | 0.01% |
40
+35
| +700% | +$11.3K |
|
638
Brink's
BCO
$4.82B
| $12.9K | 0.01% |
145
-242
| -63% | -$21.6K |
|
639
Adaptive Biotechnologies
ADPT
$1.92B
| $12.9K | 0.01% |
+1,106
| New | +$12.9K |
|
640
Oric Pharmaceuticals
ORIC
$1.06B
| $12.9K | 0.01% |
1,267
+917
| +262% | +$9.31K |
|
641
Warner Bros
WBD
$30.4B
| $12.6K | 0.01% |
1,101
+926
| +529% | +$10.6K |
|
642
Park Hotels & Resorts
PK
$2.34B
| $12.6K | 0.01% |
1,229
+286
| +30% | +$2.93K |
|
643
Supernus Pharmaceuticals
SUPN
$2.58B
| $12.5K | 0.01% |
398
-862
| -68% | -$27.2K |
|
|
CNH
644
CNH Industrial
CNH
$14.2B
| $12.5K | 0.01% |
968
-9,506
| -91% | -$123K |
|
645
Humacyte
HUMA
$238M
| $12.5K | 0.01% |
5,995
+5,278
| +736% | +$11K |
|
646
Dyne Therapeutics
DYN
$1.88B
| $12.5K | 0.01% |
1,308
-1,784
| -58% | -$17K |
|
647
Haleon
HLN
$43.6B
| $12.4K | 0.01% |
1,197
-11,319
| -90% | -$117K |
|
648
Burlington
BURL
$17.7B
| $12.3K | 0.01% |
+53
| New | +$12.3K |
|
|
MREO
649
Mereo BioPharma
MREO
$290M
| $12.3K | 0.01% |
4,544
+3,060
| +206% | +$8.29K |
|
650
MarketAxess Holdings
MKTX
$7.03B
| $12.3K | 0.01% |
55
+17
| +45% | +$3.8K |
|